November 18, 2026
Breaking
Business

Hims & Hers launches new peptide treatments — while admitting there's more to learn about efficacy

admin1 min read

The telehealth company will now offer compounded forms of sermorelin, glutathione, NAD+, vitamin B-12 and L-carnitine, none of which are approved by the FDA.

The post Hims & Hers launches new peptide treatments — while admitting there's more to learn about efficacy appeared first on Business News.

Leave a Comment

Your email address will not be published. Required fields are marked *